Searched over 200M research papers for "statin injection"
10 papers analyzed
These studies suggest that statin injections may improve neurological outcomes after ischemic stroke, enhance olfactory neuroregenesis, alter lipid synthesis in sebaceous glands, suppress atherosclerosis, stimulate bone formation, protect against cerebral ischemia, reduce breast tumor progression, mitigate doxorubicin-induced cardiotoxicity, prevent contrast-induced kidney injury, and improve cerebrovascular reactivity.
20 papers analyzed
Statins, primarily known for their lipid-lowering properties, have shown significant neuroprotective effects in ischemic stroke models. A meta-analysis of various studies on murine models of transient middle cerebral artery occlusion (tMCAO) revealed that statin administration significantly reduces infarct volume, edema, and neurological deficits. Among the different statins, simvastatin and pravastatin were particularly effective in reducing infarct volume, with pravastatin also showing superior functional outcomes. Subcutaneous injection emerged as the most effective method of administration for these outcomes.
Statin therapy has also been found to reduce blood-brain barrier (BBB) breakdown and edema, which are critical factors in the pathology of ischemic stroke. This reduction in BBB breakdown and edema further supports the potential of statins in improving neurological outcomes post-stroke.
Statins have demonstrated the ability to enhance the recovery of the olfactory epithelium (OE) damaged by olfactotoxicants like 3-methylindole (3MI). In a study involving Sprague-Dawley rats, atorvastatin treatment led to a significant increase in OE thickness and immunoreactivity to proliferating cell nuclear antigen (PCNA) and protein gene product (PGP) 9.5, indicating enhanced proliferation and neuroregeneration compared to steroid-treated and control groups.
In diabetic and non-diabetic mice, statin therapy did not significantly alter epidermal or dermal thickness but did cause cystic dilatations in hair follicles and changes in sebaceous glands, suggesting altered lipid synthesis in these tissues.
In a model of Kawasaki disease-like vasculitis, statin treatment significantly inhibited atherosclerosis and inflammatory cell invasion in the aorta. This suggests that statins could be beneficial for secondary prevention of cardiovascular events in chronic Kawasaki disease.
Statins have shown promise in enhancing bone formation both in vitro and in rodent models. Lovastatin and simvastatin, when injected subcutaneously, increased bone formation and cancellous bone volume, indicating potential therapeutic applications for osteoporosis.
Pre-treatment with statins in diabetic mice significantly reduced infarct volume and neurological disability following focal cerebral ischemia. This suggests that statins may improve stroke outcomes in diabetic patients, in addition to reducing stroke incidence.
Statins have exhibited anti-tumor effects by reducing PD-L1 expression in triple-negative breast cancer (TNBC) cells and macrophages, thereby impairing tumor progression. In xenograft mouse models, lovastatin treatment significantly suppressed primary tumor growth and metastasis.
Fluvastatin pretreatment has been shown to attenuate doxorubicin-induced cardiotoxicity in mice by improving left ventricular function and reducing oxidative stress, inflammation, and apoptotic mechanisms.
In a rat model of contrast-induced acute kidney injury (CI-AKI), atorvastatin and rosuvastatin were effective in ameliorating renal function and histopathological alterations, whereas simvastatin was less effective. This indicates that different statins may have varying protective effects against CI-AKI.
Low-dose simvastatin treatment improved cerebrovascular reactivity in patients with a history of ischemic stroke, suggesting that the stroke protection observed in clinical trials may be due to enhanced vascular endothelial function and anti-inflammatory effects.
Statin injections have demonstrated a wide range of therapeutic benefits across various models, including neuroprotection in ischemic stroke, enhanced tissue regeneration, cardiovascular protection, anti-tumor effects, and improved outcomes in diabetic and chemotherapy-induced conditions. These findings underscore the potential of statins beyond their traditional use in lipid lowering, paving the way for broader clinical applications.
Most relevant research papers on this topic